Anti-Inflammatory Therapeutics Market worth USD 130,801.9 million by 2030

The Market Statsville Group (MSG) publishes the new report on the "Anti-Inflammatory Therapeutics Market by Drug Class Outlook (Nonsteroidal Anti-inflammatory Diseases, Corticosteroids, and Biologics), by Treatment (Arthritis, Respiratory Disease, Multiple Sclerosis, Psoriasis, and Anti-inflammatory Bowel Disease), by End-Users (Hospitals, Homecare, Specialty Clinics, and Others)."

The global anti-inflammatory therapeutics market size is expected to grow to USD 130,801.9 million by 2030 from USD 95,575.7 million in 2021, at a CAGR of 4.0% during the forecast period. An increase in the incidence of autoimmune & respiratory conditions, new drugs in the pipeline, and a surge in the adoption of anti-inflammatory drugs are the key driving forces of the global anti-inflammatory market. In addition, the demand for anti-inflammatory drugs has been increasing considerably, owing to the emergence of anti-inflammatory biologics that are more targeted, effective, and with lesser side effects as compared to conventional drugs. Moreover, increased awareness of anti-inflammatory therapeutics significantly contributes to the market's growth. However, pending patent expirations of innovative drugs and higher incidence of side effects of anti-inflammatory drugs hamper the market growth.

Global Anti-Inflammatory Therapeutics Market Segmentation

The overall anti-inflammatory therapeutics market has been segmented into the drug class, treatment, end-users, and region.

• By Drug Class Outlook (Nonsteroidal Anti-inflammatory Diseases, Corticosteroids, and Biologics)
• By Treatment (Arthritis, Respiratory Disease, Multiple Sclerosis, Psoriasis, and Anti-inflammatory Bowel Disease)
• By End-Users (Hospitals, Homecare, Specialty Clinics, and Others)
• By Region (North America, Asia Pacific, Europe, South America, and lthe Middle East & Africa)

Arthritis, by treatment, is estimated to hold the largest market share during the forecast period

On the basis of indication, the global anti-inflammatory therapeutics market is fragmented into arthritis, respiratory diseases, multiple sclerosis, psoriasis, anti-inflammatory bowel disease, and other anti-inflammatory diseases. In 2021, the arthritis segment was the highest contributor to the market, with a market share of 40.5%. Arthritis is a condition characterized by the inflammation of joints. About 200 types of arthritis conditions are prevalent across the globe. Commonly, all types of arthritis cause painful joints, swollen knees, and muscle weakness. The most common types of arthritis are rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, psoriatic arthritis, and gout. Among these, the incidence rate of osteoarthritis is substantially high. Arthritis can be classified depending on the affected body part. Arthritis can be classified into soft tissue musculoskeletal pain, degenerative or mechanical arthritis, anti-inflammatory arthritis, metabolic arthritis, and infectious arthritis.

Therapeutics used to treat arthritis largely depend on the type of arthritis being treated. The arthritis treatment majorly focuses on reducing the symptoms and improving the functionality of the joints affected. Various types of anti-inflammatory therapeutics used in treating arthritis are NSAIDs, corticosteroids, and anti-inflammatory biologics. Counterirritants, analgesics, disease-modifying antirheumatic drugs (DMARDs) are used.

Don't miss out on business opportunities in Anti-Inflammatory Therapeutics Market. Speak to our research analyst and gain crucial market insights that will benefit your business grow.

North America accounts for the largest market share in anti-inflammatory therapeutics market in 2021

Based on the regions, the global anti-inflammatory therapeutics market has been segmented across North America, Asia-Pacific, Europe, South America, and the Middle East & Africa. In 2021, North America accounted for the highest market share of 37.2% in the global anti-inflammatory therapeutics market and was anticipated to maintain its dominance throughout the forecast period. The North America anti-inflammatory therapeutics market is analyzed in three countries—the U.S., Canada, and Mexico. North America is projected to grow rapidly during the forecast period due to a significant increase in the geriatric population.

The major trend in North America is continuous R&D toward developing innovative anti-inflammatory therapeutics drugs. Moreover, factors such as the surge in the aging population, a rise in the incidence of anti-inflammatory disorders, rapid adoption of patented drugs, and established reimbursement policies are driving the market growth. Furthermore, the prevalence of autoimmune and anti-inflammatory diseases is increasing in this region.

This research report includes a study on the development and marketing strategies, along with a study on the product portfolios and winning strategies of the leading companies operating in the anti-inflammatory therapeutics market. It also consists of the profiles of leading companies such as AstraZeneca PLC., Amgen Inc., Eli Lily and Company, Johnson & Johnson, GlaxoSmithKline, F. Hoffman, Abbvie, Inc., Merck & CO., Inc., Novartis, Pfizer, Inc., La Roche AG, Ferring Pharmaceuticals, Bioventus, Zimmer Biomet Holdings, Inc., and Flexion Therapeutics, Inc. These market players have focused on acquisitions and expansion to gain a larger market share in the anti-inflammatory therapeutics market.

Browse the complete report: https://www.marketstatsville.com/anti-inflammatory-therapeutics-market

About Market Statsville Group

Market Statsville Group (MSG) is a business research and consulting platform of Statsville Consulting Private Limited, based in Oklahoma, USA. MSG is the leading market research and strategy builder with the depth and breadth of solutions that perfectly suit your every need. MSG provides solutions in a wide range of industry verticals in market sizing, analysis, and intelligent business insights. MSG has experienced research analysts who are proficient at digging deep and providing various customizable data that help you make decisions with clarity, confidence, and impact. Furthermore, Market Statsville Group already benefited more than 1,000 companies each year for their revenue planning. It helped them take their disruptions/innovations early to the market by providing them research ahead of the curve.

MSG has an entire repository of research reports on more than 1,000 niche industries, 3,000 high-growth potentials markets, 5,000 data sets, and more than 12,000 company profiles.

Contact Us:

Market Statsville Group

416, East Standsberry Street, Perkins, Oklahoma 74059, USA

USA: +1-580-205-2707 | +91 702 496 8807

Email: sales@marketstatsville.com

Web: www.marketstatsville.com